董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Philip I. Smith | 男 | Chairman of the Board | 57 | 未披露 | 未持股 | 2021-03-19 |
| Philip I. Smith | 男 | Chairman of the Board | 58 | 17.95万美元 | 未持股 | 2021-03-19 |
| Scott Longval | 男 | President, Chief Executive Officer and Director | 44 | 65.01万美元 | 未持股 | 2021-03-19 |
| Raymond O. Huggenberger | 男 | Director | 66 | 14.75万美元 | 未持股 | 2021-03-19 |
| Heather D. Rider | 女 | Director | 65 | 13.42万美元 | 未持股 | 2021-03-19 |
| Kathleen P. Pepski | 女 | Director | 44 | 未披露 | 未持股 | 2021-03-19 |
| Robert N. Masucci | 男 | Director | 87 | 14.38万美元 | 未持股 | 2021-03-19 |
| Mark S. Gorder | 男 | Director | 78 | 151.90万美元 | 未持股 | 2021-03-19 |
| Nicholas A. Giordano | 男 | Director | 82 | 15.25万美元 | 未持股 | 2021-03-19 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Scott Longval | 男 | President, Chief Executive Officer and Director | 44 | 65.01万美元 | 未持股 | 2021-03-19 |
| Ellen Scipta | 女 | Chief Financial Officer | 48 | 未披露 | 未持股 | 2021-03-19 |
| Michael P. Geraci | 男 | Senior Vice President, Sales and Marketing | 62 | 38.16万美元 | 未持股 | 2021-03-19 |
| Dennis L. Gonsior | 男 | Senior Vice President, Global Operations | 62 | 36.28万美元 | 未持股 | 2021-03-19 |
董事简历
中英对照 | 中文 | 英文- Philip I. Smith
-
PhilipI.Smith于2016年4月成为董事。史密斯先生自2017年3月起担任投资银行公司Duff&Phelps的董事总经理，专注于梦百合行业。在此之前，Smith先生是投资银行公司BMO Capital Markets（前身为Greene Holcomb Fisher）的董事总经理。在2011年加入Greene Holcomb Fisher之前，Smith先生是Angeion Corporation（现为MGC Diagnostics，一家全球医疗技术公司）的总裁兼首席执行官。早期的经历包括担任DGIMED Ortho的首席执行官，Vital Images的业务发展执行Vice President，以及Piper Jaffray的梦百合投资银行家。
Philip I. Smith became a director in April 2016. Mr. Smith has served as a managing director at the investment banking firm, Duff & Phelps beginning in March 2017 where he focuses on the healthcare industry. Prior to that, Mr. Smith was a managing director with the investment banking firm, BMO Capital Markets formerly Greene Holcomb Fisher. Prior to joining Greene Holcomb Fisher in 2011 Mr. Smith was President and Chief Executive Officer of Angeion Corporation, now MGC Diagnostics, a global medical technology company. Earlier experiences include being CEO of DGIMED Ortho, Executive Vice President of Business Development at Vital Images, and a healthcare investment banker at Piper Jaffray. - PhilipI.Smith于2016年4月成为董事。史密斯先生自2017年3月起担任投资银行公司Duff&Phelps的董事总经理，专注于梦百合行业。在此之前，Smith先生是投资银行公司BMO Capital Markets（前身为Greene Holcomb Fisher）的董事总经理。在2011年加入Greene Holcomb Fisher之前，Smith先生是Angeion Corporation（现为MGC Diagnostics，一家全球医疗技术公司）的总裁兼首席执行官。早期的经历包括担任DGIMED Ortho的首席执行官，Vital Images的业务发展执行Vice President，以及Piper Jaffray的梦百合投资银行家。
- Philip I. Smith became a director in April 2016. Mr. Smith has served as a managing director at the investment banking firm, Duff & Phelps beginning in March 2017 where he focuses on the healthcare industry. Prior to that, Mr. Smith was a managing director with the investment banking firm, BMO Capital Markets formerly Greene Holcomb Fisher. Prior to joining Greene Holcomb Fisher in 2011 Mr. Smith was President and Chief Executive Officer of Angeion Corporation, now MGC Diagnostics, a global medical technology company. Earlier experiences include being CEO of DGIMED Ortho, Executive Vice President of Business Development at Vital Images, and a healthcare investment banker at Piper Jaffray.
- Philip I. Smith
-
Philip I. Smith先生于2016年4月成为Intricon Corporation董事。Smith先生自2017年3月起担任投资银行公司Duff & Phelps的董事总经理，专注于医疗保健行业。在此之前，他是投资银行公司BMO Capital Markets（原名Greene Holcomb Fisher）的董事总经理。在2011年加入Greene Holcomb Fisher之前，他是Angeion Corporation（现为MGC Diagnostics，一家全球医疗技术公司）的总裁兼首席执行官。于2008年12月被任命为DGIMed Ortho的总裁兼总经理。DGIMed Ortho是一家处于早期阶段的医疗器械公司。此前在2005年9月至2008年8月期间，Smith先生曾担任Vital Images有限公司的执行副总裁。2004年1月至2005年9月，Smith先生曾担任Vital Images有限公司副总裁，负责市场营销和企业发展。2003年2月至2004年1月，他曾担任该公司的企业发展副总裁。2002年4月至2002年11月，Smith先生曾担任一家医疗技术公司--Thermonix公司的总裁兼总经理。2000年4月至2002年4月，Smith先生曾是一家医疗技术公司--mage-Guided Neurologics有限公司的市场营销与企业发展部副主管。1997年8月至2000年2月，Smith先生曾是US Bancorp Piper Jaffray的医疗技术集团的一位银行投资家。在1997年8月之前，Smith先生曾在通用电气医疗系统（GE Medical Systems）担任高级销售职务。Smith先生拥有佛罗里达大学（ University of Florida）的电子工程学士学位，以及宾夕法尼亚大学（University of Pennsylvania）沃顿商学院的工商管理硕士学位。
Philip I. Smith has over 30 years of board, strategic advisory and operational leadership experience in the healthcare indtry, predominantly with medical device companies. Mr. Smith is currently Operating Partner at Altaris Capital Partners, LLC. Mr. Smith was a managing director at investment banking firms Kroll (formerly Duff & Phelps), BMO Capital Markets (formerly Greene Holcomb Fisher) and Piper Jaffray, where he advised healthcare clients and executed mergers, acquisitions and corporate finance transactions. Mr. Smith has significant experience as a board member, including nearly a decade on Delta Dental of Minnesota's Board of Directors and currently serving on the Board of Directors of Winmark Corporation and Trean Insurance Group, Inc. Mr. Smith received a B.S. in Electrical & Electronics Engineering from the University of Florida, and an M.B.A. in Finance from The Wharton School, University of Pennsylvania. - Philip I. Smith先生于2016年4月成为Intricon Corporation董事。Smith先生自2017年3月起担任投资银行公司Duff & Phelps的董事总经理，专注于医疗保健行业。在此之前，他是投资银行公司BMO Capital Markets（原名Greene Holcomb Fisher）的董事总经理。在2011年加入Greene Holcomb Fisher之前，他是Angeion Corporation（现为MGC Diagnostics，一家全球医疗技术公司）的总裁兼首席执行官。于2008年12月被任命为DGIMed Ortho的总裁兼总经理。DGIMed Ortho是一家处于早期阶段的医疗器械公司。此前在2005年9月至2008年8月期间，Smith先生曾担任Vital Images有限公司的执行副总裁。2004年1月至2005年9月，Smith先生曾担任Vital Images有限公司副总裁，负责市场营销和企业发展。2003年2月至2004年1月，他曾担任该公司的企业发展副总裁。2002年4月至2002年11月，Smith先生曾担任一家医疗技术公司--Thermonix公司的总裁兼总经理。2000年4月至2002年4月，Smith先生曾是一家医疗技术公司--mage-Guided Neurologics有限公司的市场营销与企业发展部副主管。1997年8月至2000年2月，Smith先生曾是US Bancorp Piper Jaffray的医疗技术集团的一位银行投资家。在1997年8月之前，Smith先生曾在通用电气医疗系统（GE Medical Systems）担任高级销售职务。Smith先生拥有佛罗里达大学（ University of Florida）的电子工程学士学位，以及宾夕法尼亚大学（University of Pennsylvania）沃顿商学院的工商管理硕士学位。
- Philip I. Smith has over 30 years of board, strategic advisory and operational leadership experience in the healthcare indtry, predominantly with medical device companies. Mr. Smith is currently Operating Partner at Altaris Capital Partners, LLC. Mr. Smith was a managing director at investment banking firms Kroll (formerly Duff & Phelps), BMO Capital Markets (formerly Greene Holcomb Fisher) and Piper Jaffray, where he advised healthcare clients and executed mergers, acquisitions and corporate finance transactions. Mr. Smith has significant experience as a board member, including nearly a decade on Delta Dental of Minnesota's Board of Directors and currently serving on the Board of Directors of Winmark Corporation and Trean Insurance Group, Inc. Mr. Smith received a B.S. in Electrical & Electronics Engineering from the University of Florida, and an M.B.A. in Finance from The Wharton School, University of Pennsylvania.
- Scott Longval
-
Scott Longval，1993年10月加入公司（Intricon Corporation），当时 Resistance Technology, Inc.（现为IntriCon, Inc.）被本公司收购。他是RTI的创始人之一，并从1977年开始担任总裁。他于1996年升职为公司（Intricon Corporation）的副总裁并担任董事会成员。2000年12月，他当选为公司的总裁和首席运营官。2001年4月，他当选为公司的首席执行官。2005年9月至2006年，他担任公司的财务主管。 2006年开始，他担任公司的首席财务官。 1998年9月至2002年4月，他受聘于Arthur Andersen，是高级审计。2002年5月至2005年3月，他受聘于Accellent, Inc.（前身为MedSource Technologies），担任财务计划和分析经理，这是一家医疗器械行业外包解决方案供应商。2005年3月至2005年9月，他担任ADC Telecommunications, Inc.的项目分析主管，这是一家创新网络基础设施产品和服务供应商。 他持有St. Olaf College的数学学士学位、 University of Minnesota的电气工程学士学位、University of St. Thomas。的会计学学士学位和University of Minnesota工商管理硕士学位。
Scott Longval was appointed as the Company's President and Chief Executive Officer and a director effective October 1 2020. Prior to that Mr. Longval served as Executive Vice President since January 2019 and Chief Operating Officer (since April 2019). Mr. Longval also served as Chief Financial Officer from July 2006 through February 8 2021 and, prior to that, as the Company's Corporate Controller from September 2005. Prior to joining the Company, Mr. Longval was Principal Project Analyst at ADC Telecommunications, Inc., a provider of innovative network infrastructure products and services, from March 2005 until September 2005. From May 2002 until March 2005 he was employed by Accellent, Inc., formerly MedSource Technologies, a provider of outsourcing solutions to the medical device industry, most recently as Manager of Financial Planning and Analysis. From September 1998 until April 2002 he was employed by Arthur Andersen, most recently as experienced audit senior. Mr. Longval received a Bachelor of Science degree in Accounting from the University of St. Thomas. - Scott Longval，1993年10月加入公司（Intricon Corporation），当时 Resistance Technology, Inc.（现为IntriCon, Inc.）被本公司收购。他是RTI的创始人之一，并从1977年开始担任总裁。他于1996年升职为公司（Intricon Corporation）的副总裁并担任董事会成员。2000年12月，他当选为公司的总裁和首席运营官。2001年4月，他当选为公司的首席执行官。2005年9月至2006年，他担任公司的财务主管。 2006年开始，他担任公司的首席财务官。 1998年9月至2002年4月，他受聘于Arthur Andersen，是高级审计。2002年5月至2005年3月，他受聘于Accellent, Inc.（前身为MedSource Technologies），担任财务计划和分析经理，这是一家医疗器械行业外包解决方案供应商。2005年3月至2005年9月，他担任ADC Telecommunications, Inc.的项目分析主管，这是一家创新网络基础设施产品和服务供应商。 他持有St. Olaf College的数学学士学位、 University of Minnesota的电气工程学士学位、University of St. Thomas。的会计学学士学位和University of Minnesota工商管理硕士学位。
- Scott Longval was appointed as the Company's President and Chief Executive Officer and a director effective October 1 2020. Prior to that Mr. Longval served as Executive Vice President since January 2019 and Chief Operating Officer (since April 2019). Mr. Longval also served as Chief Financial Officer from July 2006 through February 8 2021 and, prior to that, as the Company's Corporate Controller from September 2005. Prior to joining the Company, Mr. Longval was Principal Project Analyst at ADC Telecommunications, Inc., a provider of innovative network infrastructure products and services, from March 2005 until September 2005. From May 2002 until March 2005 he was employed by Accellent, Inc., formerly MedSource Technologies, a provider of outsourcing solutions to the medical device industry, most recently as Manager of Financial Planning and Analysis. From September 1998 until April 2002 he was employed by Arthur Andersen, most recently as experienced audit senior. Mr. Longval received a Bachelor of Science degree in Accounting from the University of St. Thomas.
- Raymond O. Huggenberger
-
Raymond O. Huggenberger自2019年5月起担任Intricon Corporation的董事。他目前任职于上市的医疗设备公司Inogen Inc.(2008年以来)和Tactile Systems Technology Inc.(2017年以来)的董事会，以及私营医疗设备公司Sommetrics, Inc.、阐明医疗公司(阐明医疗公司)和Ebb Therapeutics、Wellfount Corporation(私营制药服务公司)的董事会。Huggenberger先生此前曾担任IYIA Technologies(医疗保健公司)的董事会成员。他曾担任Inogen的首席执行官(从2008年到2017年2月)，也曾担任Inogen的总裁(从2008年到2016年1月)。加入Inogen之前，Huggenberger先生在Sunrise Medical Inc.(耐用医疗设备的全球制造商和分销商)担任多个管理职位，最终担任总裁和首席运营官。
Raymond O. Huggenberger has served as a member of Intricon Corporation of directors since May 2019. Mr. Huggenberger currently serves on the boards of publicly-traded medical device companies Inogen Inc. since 2008 and Tactile Systems Technology Inc. since 2017 as well as privately held medical device companies Sommetrics, Inc., Clarify Medical Inc. and Ebb Therapeutics, and Wellfount Corporation, a privately held pharmacy services company. Mr. Huggenberger previously served on the board of IYIA Technologies, a healthcare company. Mr. Huggenberger served as Inogen's Chief Executive Officer from 2008 to February 2017 and also served as Inogen's President from 2008 until January 2016. Prior to joining Inogen, Mr. Huggenberger held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, culminating as its President and Chief Operating Officer. - Raymond O. Huggenberger自2019年5月起担任Intricon Corporation的董事。他目前任职于上市的医疗设备公司Inogen Inc.(2008年以来)和Tactile Systems Technology Inc.(2017年以来)的董事会，以及私营医疗设备公司Sommetrics, Inc.、阐明医疗公司(阐明医疗公司)和Ebb Therapeutics、Wellfount Corporation(私营制药服务公司)的董事会。Huggenberger先生此前曾担任IYIA Technologies(医疗保健公司)的董事会成员。他曾担任Inogen的首席执行官(从2008年到2017年2月)，也曾担任Inogen的总裁(从2008年到2016年1月)。加入Inogen之前，Huggenberger先生在Sunrise Medical Inc.(耐用医疗设备的全球制造商和分销商)担任多个管理职位，最终担任总裁和首席运营官。
- Raymond O. Huggenberger has served as a member of Intricon Corporation of directors since May 2019. Mr. Huggenberger currently serves on the boards of publicly-traded medical device companies Inogen Inc. since 2008 and Tactile Systems Technology Inc. since 2017 as well as privately held medical device companies Sommetrics, Inc., Clarify Medical Inc. and Ebb Therapeutics, and Wellfount Corporation, a privately held pharmacy services company. Mr. Huggenberger previously served on the board of IYIA Technologies, a healthcare company. Mr. Huggenberger served as Inogen's Chief Executive Officer from 2008 to February 2017 and also served as Inogen's President from 2008 until January 2016. Prior to joining Inogen, Mr. Huggenberger held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, culminating as its President and Chief Operating Officer.
- Heather D. Rider
-
Heather D. Rider，她于2020年3月20日被任命为董事会成员。她目前任职于上市的医疗设备公司Inogen Inc.的董事会（2014年以来）。从2012年到2013年，她担任Cymer, Inc.（半导体制造光源的上市供应商，于2013年被ASML Holding NV收购）的全球人力资源副总裁。2010年10月至2012年9月，她担任Alphatec Holdings, Inc.（一家上市的医疗设备公司，专注于脊柱疾病的外科治疗）的全球人力资源高级副总裁，2006年至2010年，她担任Intuitive surgical, Inc.的人力资源副总裁，机器人手术系统的上市制造商。从2001年到2005年，她担任Sunrise Medical, Inc.（耐用医疗设备的全球制造商和分销商）的全球人力资源高级副总裁。从1998年到2001年，她担任Biosense Webster人力资源副总裁，该公司是Johnson & Johnson家族公司和医疗设备制造商的成员。1998年之前，她曾担任City of Hope（癌症、糖尿病和其他威胁生命的疾病的领先研究和治疗中心）的人力资源主管，CAP/MPT（加州医生的医疗事故提供者，大型医生团体和医院的医疗事故保险）的人力资源主管。以及环境诊断国际公司（Environmental Diagnostics International），一家专注于使用单克隆抗体技术检测环境化合物和疾病的生物诊断公司。
Heather D. Rider was appointed to the Board effective March 20 2020. Ms. Rider currently serves on the board of publicly-traded medical device company Inogen Inc. since 2014. From 2012 to 2013 Ms. Rider served as Vice President, Global Human Resources of Cymer, Inc., a publicly-traded supplier of light sources for semiconductor manufacturing that was acquired by ASML Holding NV in 2013. From October 2010 to September 2012 Ms. Rider served as Senior Vice President, Global Human Resources of Alphatec Holdings, Inc., a publicly-traded medical device company focused on surgical treatment of spine disorders, and from 2006 to 2010 she served as Vice President, Human Resources of Intuitive Surgical, Inc., a publicly-traded manufacturer of robotic surgical systems. From 2001 to 2005 Ms. Rider served as Senior Vice President of Global Human Resources of Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment. From 1998 to 2001 Ms. Rider served as Vice President of Human Resources of Biosense Webster, a member of the Johnson & Johnson family of companies, and a medical device manufacturer. Prior to 1998 Ms. Rider served as Head of Human Resources for City of Hope, a leading research and treatment center for cancer, diabetes and other life-threatening diseases, CAP/MPT, a medical malpractice provider for physicians in California and medical malpractice insurance for large physician groups and hospitals, and Environmental Diagnostics International, a bio-diagnostics company with focus on the detection of environmental compounds and diseases using monoclonal antibody technology. - Heather D. Rider，她于2020年3月20日被任命为董事会成员。她目前任职于上市的医疗设备公司Inogen Inc.的董事会（2014年以来）。从2012年到2013年，她担任Cymer, Inc.（半导体制造光源的上市供应商，于2013年被ASML Holding NV收购）的全球人力资源副总裁。2010年10月至2012年9月，她担任Alphatec Holdings, Inc.（一家上市的医疗设备公司，专注于脊柱疾病的外科治疗）的全球人力资源高级副总裁，2006年至2010年，她担任Intuitive surgical, Inc.的人力资源副总裁，机器人手术系统的上市制造商。从2001年到2005年，她担任Sunrise Medical, Inc.（耐用医疗设备的全球制造商和分销商）的全球人力资源高级副总裁。从1998年到2001年，她担任Biosense Webster人力资源副总裁，该公司是Johnson & Johnson家族公司和医疗设备制造商的成员。1998年之前，她曾担任City of Hope（癌症、糖尿病和其他威胁生命的疾病的领先研究和治疗中心）的人力资源主管，CAP/MPT（加州医生的医疗事故提供者，大型医生团体和医院的医疗事故保险）的人力资源主管。以及环境诊断国际公司（Environmental Diagnostics International），一家专注于使用单克隆抗体技术检测环境化合物和疾病的生物诊断公司。
- Heather D. Rider was appointed to the Board effective March 20 2020. Ms. Rider currently serves on the board of publicly-traded medical device company Inogen Inc. since 2014. From 2012 to 2013 Ms. Rider served as Vice President, Global Human Resources of Cymer, Inc., a publicly-traded supplier of light sources for semiconductor manufacturing that was acquired by ASML Holding NV in 2013. From October 2010 to September 2012 Ms. Rider served as Senior Vice President, Global Human Resources of Alphatec Holdings, Inc., a publicly-traded medical device company focused on surgical treatment of spine disorders, and from 2006 to 2010 she served as Vice President, Human Resources of Intuitive Surgical, Inc., a publicly-traded manufacturer of robotic surgical systems. From 2001 to 2005 Ms. Rider served as Senior Vice President of Global Human Resources of Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment. From 1998 to 2001 Ms. Rider served as Vice President of Human Resources of Biosense Webster, a member of the Johnson & Johnson family of companies, and a medical device manufacturer. Prior to 1998 Ms. Rider served as Head of Human Resources for City of Hope, a leading research and treatment center for cancer, diabetes and other life-threatening diseases, CAP/MPT, a medical malpractice provider for physicians in California and medical malpractice insurance for large physician groups and hospitals, and Environmental Diagnostics International, a bio-diagnostics company with focus on the detection of environmental compounds and diseases using monoclonal antibody technology.
- Kathleen P. Pepski
-
Kathleen P. Pepski 自2008年2月任公司副总裁，首席财务官及财务主管。自2008年2月至2008年11月任公司秘书长。自2003年至2007年曾任PNA股份有限公司及Katun公司（一家商业零部件提供商）执行副总裁及首席财务官，自2002年至2003年任Hoffman Enclosures公司财政部副总裁，该公司为Pentair公司子公司，主要生产系统附件，自2000年至2001年任BMC工业有限公司高级副总裁及首席财务官，该公司主要生产制造透镜孔径口罩，自1994年至2000年为Valspar公司副总裁及财务主任，该公司是油漆和涂料生产商。
Kathleen P. Pepski has been our Vice President, Chief Financial Officer and Treasurer since February 2008 and was Secretary from February 2008 to November 2008. She was the Executive Vice President and Chief Financial Officer of PNA Holdings, LLC and Katun Corporation, a supplier of business equipment parts, from 2003 to 2007 the Vice President of Finance of Hoffman Enclosures, a manufacturer of systems enclosures and a subsidiary of Pentair, Inc., from 2002 to 2003 Senior Vice President and Chief Financial Officer of BMC Industries, Inc., a manufacturer of lenses and aperture masks, from 2000 to 2001 and Vice President and Controller at Valspar Corporation, a paint and coatings manufacturer, from 1994 to 2000. Ms. Pepski will be retiring in June of 2017. - Kathleen P. Pepski 自2008年2月任公司副总裁，首席财务官及财务主管。自2008年2月至2008年11月任公司秘书长。自2003年至2007年曾任PNA股份有限公司及Katun公司（一家商业零部件提供商）执行副总裁及首席财务官，自2002年至2003年任Hoffman Enclosures公司财政部副总裁，该公司为Pentair公司子公司，主要生产系统附件，自2000年至2001年任BMC工业有限公司高级副总裁及首席财务官，该公司主要生产制造透镜孔径口罩，自1994年至2000年为Valspar公司副总裁及财务主任，该公司是油漆和涂料生产商。
- Kathleen P. Pepski has been our Vice President, Chief Financial Officer and Treasurer since February 2008 and was Secretary from February 2008 to November 2008. She was the Executive Vice President and Chief Financial Officer of PNA Holdings, LLC and Katun Corporation, a supplier of business equipment parts, from 2003 to 2007 the Vice President of Finance of Hoffman Enclosures, a manufacturer of systems enclosures and a subsidiary of Pentair, Inc., from 2002 to 2003 Senior Vice President and Chief Financial Officer of BMC Industries, Inc., a manufacturer of lenses and aperture masks, from 2000 to 2001 and Vice President and Controller at Valspar Corporation, a paint and coatings manufacturer, from 1994 to 2000. Ms. Pepski will be retiring in June of 2017.
- Robert N. Masucci
-
Robert N. Masucci，2002年2月开始成为公司（Intricon Corporation）董事。 1990年之前，他是叉车制造商——Drexel Industries, Inc.的总裁兼首席执行官。1990年开始，他担任咨询公司——Montgomery Capital Advisors, Inc.的董事会主席。1996年开始，他担任分销公司——Barclay Brand Corporation的董事会主席。2007年，他也是中国商业生猪生产者和预混料饲料公司——Agfeed Industries, Inc.的董事。他与Giordano是近亲。
Robert N. Masucci became a director in February 2002. Mr. Masucci has served as the Chairman of the Board of Montgomery Capital Advisors, Inc., a consulting company, from 1990 to 2018 and Chairman of the Board of Barclay Brand Corporation, a distribution company, since 1996. Prior to 1990 Mr. Masucci was President and Chief Executive Officer of Drexel Industries, Inc., a forklift manufacturer. Messrs. Masucci and Giordano are first cousins. - Robert N. Masucci，2002年2月开始成为公司（Intricon Corporation）董事。 1990年之前，他是叉车制造商——Drexel Industries, Inc.的总裁兼首席执行官。1990年开始，他担任咨询公司——Montgomery Capital Advisors, Inc.的董事会主席。1996年开始，他担任分销公司——Barclay Brand Corporation的董事会主席。2007年，他也是中国商业生猪生产者和预混料饲料公司——Agfeed Industries, Inc.的董事。他与Giordano是近亲。
- Robert N. Masucci became a director in February 2002. Mr. Masucci has served as the Chairman of the Board of Montgomery Capital Advisors, Inc., a consulting company, from 1990 to 2018 and Chairman of the Board of Barclay Brand Corporation, a distribution company, since 1996. Prior to 1990 Mr. Masucci was President and Chief Executive Officer of Drexel Industries, Inc., a forklift manufacturer. Messrs. Masucci and Giordano are first cousins.
- Mark S. Gorder
-
Mark S. Gorder，1996年1月成为本公司（Intricon Corporation）董事。1996年至2000年12月，他担任公司副总裁。2000年12月至2001年4月，他担任公司的总裁兼首席运营官。2001年4月开始，他担任公司的总裁兼首席执行官。另外，1983年开始，他担任公司子公司——IntriCon, Inc.的总裁兼首席执行官。
Mark S. Gorder became a director in January 1996. Mr. Gorder has served as the President and Chief Executive Officer of the Corporation since April 2001; President and Chief Operating Officer of the Corporation from December 2000 to April 2001; and Vice President of the Corporation from 1996 to December 2000. Mr. Gorder has been President and Chief Executive Officer of IntriCon, Inc., a subsidiary of the Corporation, since 1983. - Mark S. Gorder，1996年1月成为本公司（Intricon Corporation）董事。1996年至2000年12月，他担任公司副总裁。2000年12月至2001年4月，他担任公司的总裁兼首席运营官。2001年4月开始，他担任公司的总裁兼首席执行官。另外，1983年开始，他担任公司子公司——IntriCon, Inc.的总裁兼首席执行官。
- Mark S. Gorder became a director in January 1996. Mr. Gorder has served as the President and Chief Executive Officer of the Corporation since April 2001; President and Chief Operating Officer of the Corporation from December 2000 to April 2001; and Vice President of the Corporation from 1996 to December 2000. Mr. Gorder has been President and Chief Executive Officer of IntriCon, Inc., a subsidiary of the Corporation, since 1983.
- Nicholas A. Giordano
-
Nicholas A. Giordano，2000年12月开始成为公司（Intricon Corporation）董事。 1981年至1997年，他是费城证券交易所总裁兼首席执行官。1997年开始，他是业务顾问和投资者。1998年7月至1999年6月，他是LaSalle University的临时校长。他也是互惠基金——Wilmington Funds和Kalmar Pooled Investment Trust的受托人，还是健康保险公司——Independence Blue Cross of Philadelphia和互惠基金——The RBB Fund, Inc.的董事。此外，2007年至2008年，他还是Commerce Bancorp, Inc.的董事。他与 Masucci 是近亲。
Nicholas A. Giordano became a director in December 2000. Mr. Giordano has been a business consultant and investor since 1997. Mr. Giordano was Interim President of LaSalle University from July 1998 to June 1999. From 1981 to 1997 Mr. Giordano was President and Chief Executive Officer of the Philadelphia Stock Exchange. Mr. Giordano serves as a trustee of Wilmington Funds, a mutual fund, and as a director of Independence Blue Cross of Philadelphia, a health insurance company, and The RBB Fund, Inc., a mutual fund. Mr. Giordano also served as a trustee of the Kalmar Pooled Investment Trust, mutual fund, from 2000 to 2017 and as a director of Commerce Bancorp, Inc. in 2007-2008. - Nicholas A. Giordano，2000年12月开始成为公司（Intricon Corporation）董事。 1981年至1997年，他是费城证券交易所总裁兼首席执行官。1997年开始，他是业务顾问和投资者。1998年7月至1999年6月，他是LaSalle University的临时校长。他也是互惠基金——Wilmington Funds和Kalmar Pooled Investment Trust的受托人，还是健康保险公司——Independence Blue Cross of Philadelphia和互惠基金——The RBB Fund, Inc.的董事。此外，2007年至2008年，他还是Commerce Bancorp, Inc.的董事。他与 Masucci 是近亲。
- Nicholas A. Giordano became a director in December 2000. Mr. Giordano has been a business consultant and investor since 1997. Mr. Giordano was Interim President of LaSalle University from July 1998 to June 1999. From 1981 to 1997 Mr. Giordano was President and Chief Executive Officer of the Philadelphia Stock Exchange. Mr. Giordano serves as a trustee of Wilmington Funds, a mutual fund, and as a director of Independence Blue Cross of Philadelphia, a health insurance company, and The RBB Fund, Inc., a mutual fund. Mr. Giordano also served as a trustee of the Kalmar Pooled Investment Trust, mutual fund, from 2000 to 2017 and as a director of Commerce Bancorp, Inc. in 2007-2008.
高管简历
中英对照 | 中文 | 英文- Scott Longval
Scott Longval，1993年10月加入公司（Intricon Corporation），当时 Resistance Technology, Inc.（现为IntriCon, Inc.）被本公司收购。他是RTI的创始人之一，并从1977年开始担任总裁。他于1996年升职为公司（Intricon Corporation）的副总裁并担任董事会成员。2000年12月，他当选为公司的总裁和首席运营官。2001年4月，他当选为公司的首席执行官。2005年9月至2006年，他担任公司的财务主管。 2006年开始，他担任公司的首席财务官。 1998年9月至2002年4月，他受聘于Arthur Andersen，是高级审计。2002年5月至2005年3月，他受聘于Accellent, Inc.（前身为MedSource Technologies），担任财务计划和分析经理，这是一家医疗器械行业外包解决方案供应商。2005年3月至2005年9月，他担任ADC Telecommunications, Inc.的项目分析主管，这是一家创新网络基础设施产品和服务供应商。 他持有St. Olaf College的数学学士学位、 University of Minnesota的电气工程学士学位、University of St. Thomas。的会计学学士学位和University of Minnesota工商管理硕士学位。
Scott Longval was appointed as the Company's President and Chief Executive Officer and a director effective October 1 2020. Prior to that Mr. Longval served as Executive Vice President since January 2019 and Chief Operating Officer (since April 2019). Mr. Longval also served as Chief Financial Officer from July 2006 through February 8 2021 and, prior to that, as the Company's Corporate Controller from September 2005. Prior to joining the Company, Mr. Longval was Principal Project Analyst at ADC Telecommunications, Inc., a provider of innovative network infrastructure products and services, from March 2005 until September 2005. From May 2002 until March 2005 he was employed by Accellent, Inc., formerly MedSource Technologies, a provider of outsourcing solutions to the medical device industry, most recently as Manager of Financial Planning and Analysis. From September 1998 until April 2002 he was employed by Arthur Andersen, most recently as experienced audit senior. Mr. Longval received a Bachelor of Science degree in Accounting from the University of St. Thomas.- Scott Longval，1993年10月加入公司（Intricon Corporation），当时 Resistance Technology, Inc.（现为IntriCon, Inc.）被本公司收购。他是RTI的创始人之一，并从1977年开始担任总裁。他于1996年升职为公司（Intricon Corporation）的副总裁并担任董事会成员。2000年12月，他当选为公司的总裁和首席运营官。2001年4月，他当选为公司的首席执行官。2005年9月至2006年，他担任公司的财务主管。 2006年开始，他担任公司的首席财务官。 1998年9月至2002年4月，他受聘于Arthur Andersen，是高级审计。2002年5月至2005年3月，他受聘于Accellent, Inc.（前身为MedSource Technologies），担任财务计划和分析经理，这是一家医疗器械行业外包解决方案供应商。2005年3月至2005年9月，他担任ADC Telecommunications, Inc.的项目分析主管，这是一家创新网络基础设施产品和服务供应商。 他持有St. Olaf College的数学学士学位、 University of Minnesota的电气工程学士学位、University of St. Thomas。的会计学学士学位和University of Minnesota工商管理硕士学位。
- Scott Longval was appointed as the Company's President and Chief Executive Officer and a director effective October 1 2020. Prior to that Mr. Longval served as Executive Vice President since January 2019 and Chief Operating Officer (since April 2019). Mr. Longval also served as Chief Financial Officer from July 2006 through February 8 2021 and, prior to that, as the Company's Corporate Controller from September 2005. Prior to joining the Company, Mr. Longval was Principal Project Analyst at ADC Telecommunications, Inc., a provider of innovative network infrastructure products and services, from March 2005 until September 2005. From May 2002 until March 2005 he was employed by Accellent, Inc., formerly MedSource Technologies, a provider of outsourcing solutions to the medical device industry, most recently as Manager of Financial Planning and Analysis. From September 1998 until April 2002 he was employed by Arthur Andersen, most recently as experienced audit senior. Mr. Longval received a Bachelor of Science degree in Accounting from the University of St. Thomas.
- Ellen Scipta
Ellen Scipta，她一直担任Intricon Corporation的首席财务官（2021年2月以来）。此前，她曾担任Bio-Techne（明尼苏达州明尼阿波利斯市的生命科学和诊断产品制造商和零售商）的各种财务职位（2015年以来），最近担任财务副总裁。在此之前，她于2011年被CHS Inc.（一家多元化的全球农业综合企业合作社）聘用，最近担任企业战略总监。她曾担任Best Buy Co.， Inc.（2005-2011）和Target Corporation（2002-2005）的战略和财务职位，并曾担任Price Waterhouse Coopers LLC（1999-2001）的战略顾问。她持有印第安纳大学凯利商学院（the Kelley School of Business, Indiana University）的工商管理硕士学位，以及普渡大学（Purdue University）的航空和航天工程学士学位。
Ellen Scipta has served as Intricon Corporation's Chief Financial Officer since February 2021. Previously, Ms. Scipta served in various financial positions at Bio-Techne, a Minneapolis, Minnesota based manufacturer and retailer of life sciences and diagnostic products, since 2015 most recently as Vice President, Finance. Prior to that, Ms. Scipta was employed by CHS Inc., a diversified global agribusiness cooperative, since 2011 most recently as Director of Enterprise Strategy. Ms. Scipta held strategy and financial positions with Best Buy Co., Inc. 2005-2011 and Target Corporation (2002-2005) and was a strategy consultant with Price Waterhouse Coopers LLC (1999-2001). Ms. Scipta holds a Master of Business Administration from the Kelley School of Business, Indiana University, and a Bachelor of Science degree in Aeronautical and Astronautical Engineering from Purdue University.- Ellen Scipta，她一直担任Intricon Corporation的首席财务官（2021年2月以来）。此前，她曾担任Bio-Techne（明尼苏达州明尼阿波利斯市的生命科学和诊断产品制造商和零售商）的各种财务职位（2015年以来），最近担任财务副总裁。在此之前，她于2011年被CHS Inc.（一家多元化的全球农业综合企业合作社）聘用，最近担任企业战略总监。她曾担任Best Buy Co.， Inc.（2005-2011）和Target Corporation（2002-2005）的战略和财务职位，并曾担任Price Waterhouse Coopers LLC（1999-2001）的战略顾问。她持有印第安纳大学凯利商学院（the Kelley School of Business, Indiana University）的工商管理硕士学位，以及普渡大学（Purdue University）的航空和航天工程学士学位。
- Ellen Scipta has served as Intricon Corporation's Chief Financial Officer since February 2021. Previously, Ms. Scipta served in various financial positions at Bio-Techne, a Minneapolis, Minnesota based manufacturer and retailer of life sciences and diagnostic products, since 2015 most recently as Vice President, Finance. Prior to that, Ms. Scipta was employed by CHS Inc., a diversified global agribusiness cooperative, since 2011 most recently as Director of Enterprise Strategy. Ms. Scipta held strategy and financial positions with Best Buy Co., Inc. 2005-2011 and Target Corporation (2002-2005) and was a strategy consultant with Price Waterhouse Coopers LLC (1999-2001). Ms. Scipta holds a Master of Business Administration from the Kelley School of Business, Indiana University, and a Bachelor of Science degree in Aeronautical and Astronautical Engineering from Purdue University.
- Michael P. Geraci
Michael P. Geraci，1983年10月加入本公司（Intricon Corporation），并于1995年1月开始担任公司的销售和营销副总裁。他持有 Bradley University电气工程学士学位和University of Minnesota的Carlson商学院工商管理硕士学位。
Michael P. Geraci joined the Company in October 1983. He has served as the Company’s Vice President of Sales and Marketing since January 1995. Mr. Geraci received a Bachelor of Science degree in Electrical Engineering from Bradley University and a Master of Business Administration from the University of Minnesota - Carlson School of Business.- Michael P. Geraci，1983年10月加入本公司（Intricon Corporation），并于1995年1月开始担任公司的销售和营销副总裁。他持有 Bradley University电气工程学士学位和University of Minnesota的Carlson商学院工商管理硕士学位。
- Michael P. Geraci joined the Company in October 1983. He has served as the Company’s Vice President of Sales and Marketing since January 1995. Mr. Geraci received a Bachelor of Science degree in Electrical Engineering from Bradley University and a Master of Business Administration from the University of Minnesota - Carlson School of Business.
- Dennis L. Gonsior
Dennis L. Gonsior，于1982年2月加入公司（Intricon Corporation）。他持有Saint Cloud State University的学士学位，于1996年1月开始在本公司担任运营副总裁。
Dennis L. Gonsior joined the Company in February 1982. He has served as the Company’s Vice President of Operations since January 1996. Mr. Gonsior received a Bachelor of Science degree from Saint Cloud State University.- Dennis L. Gonsior，于1982年2月加入公司（Intricon Corporation）。他持有Saint Cloud State University的学士学位，于1996年1月开始在本公司担任运营副总裁。
- Dennis L. Gonsior joined the Company in February 1982. He has served as the Company’s Vice President of Operations since January 1996. Mr. Gonsior received a Bachelor of Science degree from Saint Cloud State University.